A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

By M. Keller, J. P. Mccullough, D. Klein, B. Arnow, D. Dunner, A. Gelenberg, J. Markowitz, C. Nemeroff, James M. Russell, M. Thase and 19 more. New England Journal of Medicine, 2000

1,335 citations recorded by the source corpus.

Subfields: Clinical Psychology, Experimental and Cognitive Psychology, Pharmacology

View Paper: https://www.semanticscholar.org/paper/5e788c5e388d01a705903652108bfad4284ce175

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Psychology

In Experimental and Cognitive Psychology

In Pharmacology

Citations in the corpus

Variable Selection for Qualitative Interactions (2011, background): “The Nefazodone CBASP trial [1] was a randomized controlled trial conducted to compare the efficacy of three alternate treatments for patients with chronic depression.”
The link between childhood trauma and depression: insights from HPA axis studies in humans. (2008, positive): “…this question, we had the opportunity to reanalyze data from a large multi-center treatment trial comparing the effectiveness of either pharmacological treatment (nefazodone ) or psychotherapy (Cognitive Behavioral Analysis System of Psychotherapy), or the combination of both (Keller et al., 2000).”
Using Decision Lists to Construct Interpretable and Parsimonious Treatment Regimes (2015, background): “Chronic Depression Data Keller et al. (2000) compared nefazodone, psychotherapy, and combination of nefazodone and psychotherapy for treating patients with chronic depression in a three-arm-randomized clinical trial.”
PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES (2011, methodology): “In this section, we develop a practical implementation of the l1-PLS method, compare this method to two commonly used alternatives and lastly illustrate the method using the motivating data from the Nefazodone-CBASP trial [13].”
Ostracism breeds depression: Longitudinal associations between ostracism and depression over a three-year-period (2021, positive): “For instance, the Cognitive Behavioral Analysis System of Psychotherapy ( Keller et al., 2000 ; McCullough Jr, 2003 ) for chronically depressed individuals could help to break vicious cycles by addressing feelings and potential causes of ostracism at the same time.”
The Long-Term Stability of Early Maladaptive Schemas (2006, methodology): “Moreover, all interviewers for the current study were highly experienced in clinical evaluation and certified in the use of the SCID-I from other research (Keller et al., 2000).”
Posttraumatic stress disorder: a state-of-the-science review. (2006, background): “Keller et al. (2000) were among the first to compare directly the efficacy of antidepressant (nefazodone) treatment, psychotherapy, and the combination of the two in the treatment of chronic depression.”
Treatment for Chronic Depression Using Schema Therapy (2013, positive): “For example, in the study by Keller et al. (2000), chronically depressed outpatients received 16 – 20 sessions of CBASP, with a mean number of 16 sessions.”
Estimating Individualized Treatment Rules Using Outcome Weighted Learning (2012, methodology): “The method is then illustrated on the Nefazodone-CBASP data (Keller et al. 2000) in Section 5.”
Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. (2008, neutral): “Income, median (range), thousands $ 60 (8-500) 62 (0-250) .”
Disorders of extreme stress: The empirical foundation of a complex adaptation to trauma. (2005, background): “For example, there is increasing evidence that having a history of child abuse may significantly change treatment outcome in other psychiatric conditions (e.g., Ford & Kidd, 1998; Keller et al., 2000; Nemeroff et al., 2003).”